Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. - Wikidata - awgldk - TriplyDB

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

http://www.wikidata.org/entity/Q36267882

about

Bipolar disorder and alcohol use disorder: a review Psychosocial interventions for people with both severe mental illness and substance misuse Psychosocial interventions for people with both severe mental illness and substance misuse Substance abuse and schizophrenia: pharmacotherapeutic intervention A roadmap to key pharmacologic principles in using antipsychotics The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems Free-running rhythms of cocaine self-administration in rats held under constant lighting conditions.Intrinsic motivation as a mediator of relationships between symptoms and functioning among individuals with schizophrenia spectrum disorders in a diverse urban community.Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.Integrating mental health and addictions services to improve client outcomes.Advisor-Teller Money Manager (ATM) therapy for substance use disorders.Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.Cigarette smoking and mortality risk in people with schizophrenia.Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs.Physical Health and Dual Diagnosis.Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders The catatonic dilemma expanded Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services.Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Implementing Residential Integrated Treatment for Co-occurring Disorders Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.Professionals' perception on the management of patients with dual disorders.Comorbid psychiatric and substance abuse disorders: recent treatment research.A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs.The efficacy of assertive community treatment to treat substance use.Helping homeless individuals with co-occurring disorders: the four components.Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care system Opiate dependence in schizophrenia: case presentation and literature review.Treatment of substance use disorders in schizophrenia.Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review Integrating services for patients with mental and substance use disorders: What matters?Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations.Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients.

P2860

Q22252584-E5C408DF-4444-40D6-A4E5-04EA2FF0589E Q24197576-042EF383-7539-452A-B5CC-3AB2D14F2DEA Q24242339-F078E8B9-A070-44F1-A127-01329A315776 Q24621711-8718DDCC-A9A9-4E08-A81E-B3BE597DE8C0 Q24678461-BE5D93A6-80B4-4A36-87D2-940404888877 Q30301208-FBED07BD-E638-42E5-ACC2-F8B752788C41 Q30366778-547F0949-EC82-47EF-BAF0-D906C5330ECD Q33500672-B451D2CE-5FDC-49BB-8F1C-1D2873DEB7E2 Q34104417-F08BA38B-721C-4846-A683-877ECBA179DF Q34160441-DBA12F84-1507-43D0-AE80-B7CBDF562A9B Q34347478-CCC0794E-A6B4-4AB5-A105-C876CD7204EB Q34373311-4E96F72A-9F7D-4FD5-8D0F-951D1CD9E020 Q34718546-B063F2C5-12C5-4F33-B131-677B1A463DD0 Q34994773-83E6B3E6-36C6-4B75-90E8-A21176C95125 Q35065406-1A900E6C-2FD5-4D7B-B6D5-731527F1B954 Q35079480-5A013FD7-E667-41B5-8FB3-FF58B32D7735 Q35663322-D8681C3C-7861-482C-9E96-39876F479B99 Q36009165-D9AE501E-DD73-4F11-B068-FB6D5D2A9656 Q36542180-893E6B5F-DF9C-44B5-ACB3-B4FBE2D68570 Q36570221-323BACEE-4479-40B4-A81B-C3EEAB6A2BDE Q36588430-ED761CE3-4B68-49B6-AB03-26079FE1201E Q36957061-9306758D-0C41-45E1-8CDC-100E7EC33DF2 Q37010033-E72B92C7-2573-4E99-8707-434F0C24BC45 Q37079797-94B8AB17-E772-44FA-A903-39065E3AB2C3 Q37102870-A54DEA57-97CE-449A-BCCB-8CB78E350241 Q37190653-7FDBE8B1-C57A-4AE4-8D84-659299A4C544 Q37279671-03F16266-45A5-44F4-8298-8F49BD4D7808 Q37337682-E96F2B05-33B2-47E3-80E6-A479B781019B Q37736729-CFFD77C2-59C7-46FA-82B8-01F431143226 Q37870700-EFB880CC-2371-4A98-90DD-16F8781D1089 Q38024372-50252741-D143-4EB3-B7DF-27DACF53BE0C Q38184528-8A19ACCE-0788-4FBA-8ED9-E6349C76E30F Q38267760-42000A75-2F83-4AC2-8FC6-A8A6D453077E Q38813826-1F1D9F93-3249-4A58-A5EB-C34A92C4AA07 Q40492690-F774DB2E-CBC8-4183-A4F8-D26BDF1CD573 Q41664978-616D07FB-1B7B-4BB3-8F94-068B1773C0B3 Q41891550-B190841C-3E8C-4D2F-BD19-3F1BAB3DBB18 Q42659528-E2887A1F-74E4-403C-A85B-703138B1CD5E Q44697721-AE17BE0F-219F-498D-85C2-E4BCB20F8264 Q46142680-2E669D81-AC5F-4DD8-B6B9-B4A7DBE3B0EC

P2860

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

http://www.wikidata.org/entity/Q36267882

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Improving the care of individu ...... rs: consensus recommendations.

@ast

Improving the care of individu ...... rs: consensus recommendations.

@en

type

label

Improving the care of individu ...... rs: consensus recommendations.

@ast

Improving the care of individu ...... rs: consensus recommendations.

@en

prefLabel

Improving the care of individu ...... rs: consensus recommendations.

@ast

Improving the care of individu ...... rs: consensus recommendations.

@en

P1433

Q36267882-46060BAC-8BAA-4D92-BB26-3466FEA8F14E

P1476

Q36267882-995EC485-F6BE-4D25-8435-D6257E9A7F5B

P2093

Q36267882-048B27CD-2DB1-4741-A1A0-0F5D0189E879

Q36267882-0626BDBF-E00F-4AAD-8C6A-ADDF6F952562

Q36267882-284C2DBA-E92B-4185-97C4-71B014B7B071

Q36267882-2DA4A32F-85FA-46E5-9262-AEF4C78CB357

Q36267882-370C1406-0A7A-43C9-BBAC-3155310830EB

Q36267882-4E05B74F-31FF-487F-AACE-C8726420E618

Q36267882-8197431F-13B9-436C-BBCC-64B086DDAC81

Q36267882-D8238648-11F5-41B2-BCAE-39183F9C80BA

Q36267882-DEA2672D-D7FC-44EF-9DC1-9A3C77138CE2

P2860

Q36267882-00DB9DCC-F625-476A-BE75-CFD0EF060692

Q36267882-08EBA77D-58C3-4EEB-9C25-93DDB03712F2

Q36267882-0A8CA0DB-78BA-450B-ABBD-5AA579A98F95

Q36267882-0BA74A06-EAFE-40C8-AE02-44B3D7D20269

Q36267882-0E3595C4-73EB-46B6-B5BD-768C2E9D4FB7

Q36267882-0F481391-AC27-4FEB-94F0-AFF7C33F623E

Q36267882-16A08910-9771-4FC4-91CE-CF26D89EA7BA

Q36267882-1A9F3091-14F3-4CEC-ACAF-A632F56162EB

Q36267882-1CF71199-2C2E-4CE9-8F01-CAA5DC8CE308

Q36267882-1DDCE82D-B914-44FF-9E8E-C19265169D37

P304

Q36267882-2615C46A-5956-4A04-838D-A3E7FC9612EA

P31

Q36267882-A2B55E43-0D44-4CB5-AAE5-30CA164594E1

P356

Q36267882-49A77B11-0D6A-4485-9FB7-848C122C0A44

P433

Q36267882-525A8D3F-2CC0-424C-86CA-17785CEE88FE

P478

Q36267882-BE539B53-D8FD-4470-BA9C-69F70693A253

P577

Q36267882-F2BB0A17-F509-4CC2-B458-996947C2FF42

P5875

Q36267882-91905F4A-35B4-42BF-AF12-3A95D50B4A37

P698

Q36267882-6BF8584C-76A0-4C26-A7C3-B38465C1C145

P921

Q36267882-57F3FB2B-F70F-4F4B-B307-E9C7B70F0119

Q36267882-BFFC58A8-1EBF-4C98-9FAE-7317F7B3F089

P932

Q36267882-FC0A0EA7-11EC-4AE6-A41A-4A63DA319C1D

P356

00131746-200509000-00005

P1433

Journal of Psychiatric Practice

P1476

Improving the care of individu ...... rs: consensus recommendations.

@en

P2093

Alan I Green

http://www.w3.org/2001/XMLSchema#string

David Smelson

http://www.w3.org/2001/XMLSchema#string

Douglas M Ziedonis

http://www.w3.org/2001/XMLSchema#string

Ivan Montoya

http://www.w3.org/2001/XMLSchema#string

Joseph Parks

http://www.w3.org/2001/XMLSchema#string

Renata J Henry

http://www.w3.org/2001/XMLSchema#string

Richard N Rosenthal

http://www.w3.org/2001/XMLSchema#string

Roger D Weiss

http://www.w3.org/2001/XMLSchema#string

Steven L Batki

http://www.w3.org/2001/XMLSchema#string

P2860

In search of how people change. Applications to addictive behaviors

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes.

Alcohol consumption and abnormalities of brain structure and vasculature.

The role of laboratory tests in alcoholism treatment.

Significant interaction between clozapine and cocaine in cocaine addicts.

Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis

Drug interactions with tobacco smoking. An update.

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.

P304

315-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00131746-200509000-00005

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7580383

http://www.w3.org/2001/XMLSchema#string

P698

16184072

http://www.w3.org/2001/XMLSchema#string

P921

P932

2599914

http://www.w3.org/2001/XMLSchema#string